Circulating and Intrapulmonary C-Reactive Protein: A Predictor of Bronchiolitis Obliterans Syndrome and Pulmonary Allograft Outcome

Journal of Heart and Lung Transplantation

Volumn 28, Issue 8, 2009, Pages 799-807

  Vos, Robin ^a   Vanaudenaerde, Bart M ^a   De Vleeschauwer, Stéphanie I ^a   Willems Widyastuti, Anna ^a   Scheers, Hans ^a   Van Raemdonck, Dirk E ^a,b   Dupont, Lieven J ^a,b   Verleden, Geert M ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; C REACTIVE PROTEIN; CYCLOSPORIN A; INTERLEUKIN 6; INTERLEUKIN 8; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LUNG GRAFT REJECTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHILIA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS;

ADULT; BRONCHIOLITIS OBLITERANS; C-REACTIVE PROTEIN; COHORT STUDIES; FEMALE; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 67650732054     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.05.011     Document Type: Article

References (47)

1. Black S., Kushner I., and Samols D. C-reactive protein. J Biol Chem 279 (2004) 48487-48490
2. Hutchinson W.L., Noble G.E., Hawkins P.N., and Pepys M.B. The pentraxins, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. J Clin Invest 94 (1994) 1390-1396
3. Kluft C., and de Maat M.P. Sensitive markers of inflammation make it possible to study the chronic process: the rise of interest in low levels of C-reactive protein. Vascul Pharmacol 39 (2002) 99-104
4. Ridker P.M., Rifai N., Pfeffer M.A., et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation 98 (1998) 839-844
5. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
6. Winkelmayer W.C., Schaeffner E.S., Chandraker A., et al. A J-shaped association between high-sensitivity C-reactive protein and mortality in kidney transplant recipients. Transpl Int 20 (2007) 505-511
7. van Ree R.M., Oterdoom L.H., de Vries A.P., et al. Elevated levels of C-reactive protein independently predict accelerated deterioration of graft function in renal transplant recipients. Nephrol Dial Transplant 22 (2007) 246-253
8. Eisenberg M.S., Chen H.J., Warshofsky M.K., et al. Elevated levels of plasma C-reactive protein are associated with decreased graft survival in cardiac transplant recipients. Circulation 102 (2000) 2100-2104
9. Dahl M., Vestbo J., Lange P., Bojesen S.E., Tybjaerg-Hansen A., and Nordestgaard B.G. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175 (2007) 250-255
10. Levy H., Kalish L.A., Huntington I., et al. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol 42 (2007) 256-262
11. Walter R.E., Wilk J.B., Larson M.G., et al. Systemic inflammation and COPD: The Framingham Heart Study. Chest 133 (2008) 19-25
12. Verleden G.M., Vanaudenaerde B.M., Dupont L.J., and Van Raemdonck D.E. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 174 (2006) 566-570
13. Riise G.C., Andersson B.A., Kjellström C., et al. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant. Eur Respir J 14 (1999) 1123-1130
14. Trulock E.P., Edwards L.B., Taylor D.O., Boucek M.M., Keck B.M., and Hertz M.I. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report-2007. J Heart Lung Transplant 26 (2007) 782-795
15. Vos R., Vanaudenaerde B.M., Dupont L.J., Van Raemdonck D.E., and Verleden G.M. Transient airway colonization is associated with airway inflammation after lung transplantation. Am J Transplant 7 (2007) 1278-1287
16. Vanaudenaerde B.M., De Vleeschauwer S.I., Vos R., et al. The role of the IL23/IL17 axis in Bronchiolitis Obliterans Syndrome after lung transplantation. Am J Transplant 8 (2008) 1911-1920
17. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 15 (1996) 1-15
18. Estenne M., Maurer J.R., Boehler A., et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297-310
19. Standardization of spirometry--1987 update. Statement of the American Thoracic Society. Am Rev Respir Dis 136 (1987) 1285-1298
20. Vos R., Vanaudenaerde B.M., Geudens N., Dupont L.J., Van Raemdonck D.E., and Verleden G.M. Pseudomonal airway colonization: a risk factor for BOS after lung transplantation?. Eur Respir J 31 (2008) 1037-1045
21. Wigmore S.J., Fearon K.C., Maingay J.P., Lai P.B., and Ross J.A. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol 273 (1997) E720-E726
22. Panichi V., Taccola D., Rizza G.M., et al. Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients. Nephron Clin Pract 102 (2006) c51-c58
23. Dong Q., and Wright J.R. Expression of C-reactive protein by alveolar macrophages. J Immunol 156 (1996) 4815-4820
24. Thorn J. The inflammatory response in humans after inhalation of bacterial endotoxin: a review. Inflamm Res 50 (2001) 254-261
25. Zhong W., Zen Q., Tebo J., Schlottmann K., Coggeshall M., and Mortensen R.F. Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling. J Immunol 161 (1998) 2533-2540
26. Xie L., Chang L., Guan Y., and Wang X. C-reactive protein augments interleukin-8 secretion in human peripheral blood monocytes. J Cardiovasc Pharmacol 46 (2005) 690-696
27. Khreiss T., Jozsef L., Potempa L.A., and Filep J.G. Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ Res 97 (2005) 690-697
28. Barna B.P., Thomassen M.J., Zhou P., Pettay J., Singh-Burgess S., and Deodhar S.D. Activation of alveolar macrophage TNF and MCP-1 expression in vivo by a synthetic peptide of C-reactive protein. J Leukoc Biol 59 (1996) 397-402
29. Galve-de R.B., Wiktorowicz K., Kushner I., and Dayer J.M. C-reactive protein increases production of IL-1 alpha, IL-1 beta, and TNF-alpha, and expression of mRNA by human alveolar macrophages. J Leukoc Biol 53 (1993) 439-445
30. Li J.J., Sanders R.L., McAdam K.P., et al. Impact of C-reactive protein (CRP) on surfactant function. J Trauma 29 (1989) 1690-1697
31. Casals C., Varela A., Ruano M.L.F., et al. Increase of C-reactive protein and decrease of surfactant protein A in surfactant after lung transplantation. Am J Respir Crit Care Med 157 (1998) 43-49
32. Vos R., Vanaudenaerde B.M., De Vleeschauwer S.I., Van Raemdonck D.E., Dupont L.J., and Verleden G.M. Plasma CRP levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?. Transplant Proc 41 (2009) 595-598
33. Aronson D., Roterman I., Yigla M., et al. Inverse association between pulmonary function and C-reactive protein in apparently healthy subjects. Am J Respir Crit Care Med 174 (2006) 626-632
34. Shaaban R., Kony S., Driss F., et al. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir Med 100 (2006) 2112-2120
35. Takemura M., Matsumoto H., Niimi A., et al. High sensitivity C-reactive protein in asthma. Eur Respir J 27 (2006) 908-912
36. de Torres J.P., Cordoba-Lanus E., Lopez-Aguilar C., et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J 27 (2006) 902-907
37. Jabs W.J., Logering B.A., Gerke P., et al. The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 33 (2003) 152-161
38. Arora S., Gullestad L., Wergeland R., et al. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation. Transplantation 83 (2007) 1308-1315
39. Johnson B.A., Iacono A.T., Zeevi A., McCurry A.F., and Duncan S.R. Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med 167 (2003) 1271-1278
40. Meloni F., Fietta A., Solari N., Morosini M., and Pozzi E. Evaluation of the biological effects of atorvastatin in lung transplant recipients. Eur Respir J 30 51s (2007) 27s
41. Cascina A., Meloni F., Fietta A., Solari N., Bini F., and Lastoria C. Clinical and biological effects of chronic low dose azithromycin treatment in patients with bronchiolitis obliterans. Eur Respir J 30 51s (2007) 517s
42. Slebos D.J., Scholma J., Boezen H.M., et al. Longitudinal profile of bronchoalveolar lavage cell characteristics in patients with a good outcome after lung transplantation. Am J Respir Crit Care Med 165 (2002) 501-507
43. Gottlieb J., Szangolies J., Koehnlein T., Golpon H., Simon A., and Welte T. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation 85 (2008) 36-41
44. Tiroke A.H., Bewig B., and Haverich A. Bronchoalveolar lavage in lung transplantation. State of the art. Clin Transplant 13 (1999) 131-157
45. Paradis I.L., Marrari M., Zeevi A., et al. HLA phenotype of lung lavage cells following heart-lung transplantation. J Heart Transplant 4 (1985) 422-425
46. DiGiovine B., Lynch III J.P., Martinez F.J., et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol 157 (1996) 4194-4202
47. Henke J.A., Golden J.A., Yelin E.H., Keith F.A., and Blanc P.D. Persistent increases of BAL neutrophils as a predictor of mortality following lung transplant. Chest 115 (1999) 403-409